National Patient Advocate Foundation Launches Project at ASCO
NAPF is launching its Project Innovation, a national movement to accelerate the pace of cancer medical discovery.
The National Patient Advocate Foundation Foundation (NAPF) is launching its Project Innovation, a national movement to accelerate the pace of cancer medical discovery. The basis of the Project is outlined in its report “Securing the Future of Innovation in Cancer Treatment."
NAPF calls for an expansion on the science of innovation by streamlining logistical obstacles, which include bureaucratic, institutional, and regulatory; bolstering funding opportunities, which includes increased funding for for basic and clinical study, and heightened awareness by all stakeholders of clinical research opportunities; and improved communication and coordination between providers and patients, which focuses on enhancing enrollment of these clinical trials by improving physician awareness of clinical trials and sharing of information with their patients. The report says: "Coordination among oncology researchers, treating oncologists and patients is essential so that all parties are educated about ongoing research."
In addition, the report says regulatory policies must be established to ensure that payers cover clinical trial costs for patients.
Read the full release here.
Truqap Combination Shines in Phase III Trial for Prostate Cancer
November 26th 2024Data from the CAPItello-281 trial show Truqap alongside abiraterone and androgen deprivation therapy achieved a statistically significant and clinically meaningful improvement in radiographic progression-free survival.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
